Cogstate Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.955
- Today's High:
- $0.9552
- Open Price:
- $0.9552
- 52W Low:
- $0.79
- 52W High:
- $1.54
- Prev. Close:
- $0.91
- Volume:
- 7000
Company Statistics
- Market Cap.:
- $190.90 million
- Book Value:
- 0.195
- Revenue TTM:
- $41.50 million
- Operating Margin TTM:
- 11.42%
- Gross Profit TTM:
- $26.34 million
- Profit Margin:
- 8.43%
- Return on Assets TTM:
- 5.53%
- Return on Equity TTM:
- 11.29%
Company Profile
Cogstate Limited had its IPO on under the ticker symbol COGZF.
The company operates in the Healthcare sector and Health Information Services industry. Cogstate Limited has a staff strength of 190 employees.
Stock update
Shares of Cogstate Limited opened at $0.96 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.96 - $0.96, and closed at $0.96.
This is a +4.95% increase from the previous day's closing price.
A total volume of 7,000 shares were traded at the close of the day’s session.
In the last one week, shares of Cogstate Limited have increased by +4.95%.
Cogstate Limited's Key Ratios
Cogstate Limited has a market cap of $190.90 million, indicating a price to book ratio of 6.269 and a price to sales ratio of 4.7563.
In the last 12-months Cogstate Limited’s revenue was $41.50 million with a gross profit of $26.34 million and an EBITDA of $4.76 million. The EBITDA ratio measures Cogstate Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cogstate Limited’s operating margin was 11.42% while its return on assets stood at 5.53% with a return of equity of 11.29%.
In Q2, Cogstate Limited’s quarterly earnings growth was a negative -98.6% while revenue growth was a negative 15.3%.
Cogstate Limited’s PE and PEG Ratio
- Forward PE
- 31.0559
- Trailing PE
- 55
- PEG
- 0
Its diluted EPS in the last 12-months stands at $0.02 per share while it has a forward price to earnings multiple of 31.0559 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cogstate Limited’s profitability.
Cogstate Limited stock is trading at a EV to sales ratio of 3.6622 and a EV to EBITDA ratio of 12.5698. Its price to sales ratio in the trailing 12-months stood at 4.7563.
Cogstate Limited stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $58.45 million
- Total Liabilities
- $18.26 million
- Operating Cash Flow
- $-1446814.00
- Capital Expenditure
- $72665
- Dividend Payout Ratio
- 0%
Cogstate Limited ended 2024 with $58.45 million in total assets and $0 in total liabilities. Its intangible assets were valued at $58.45 million while shareholder equity stood at $32.92 million.
Cogstate Limited ended 2024 with $0 in deferred long-term liabilities, $18.26 million in other current liabilities, 36145605.00 in common stock, $-3252806.00 in retained earnings and $0 in goodwill. Its cash balance stood at $30.60 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Cogstate Limited’s total current assets stands at $42.00 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $10.39 million compared to accounts payable of $953367.00 and inventory worth $0.
In 2024, Cogstate Limited's operating cash flow was $-1446814.00 while its capital expenditure stood at $72665.
Comparatively, Cogstate Limited paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.96
- 52-Week High
- $1.54
- 52-Week Low
- $0.79
- Analyst Target Price
- $
Cogstate Limited stock is currently trading at $0.96 per share. It touched a 52-week high of $1.54 and a 52-week low of $1.54. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.97 and 200-day moving average was $1.11 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4253.6% of the company’s stock are held by insiders while 1624.7% are held by institutions.
Frequently Asked Questions About Cogstate Limited
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company’s cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.